<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37867460</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2691-1299</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Current protocols</Title><ISOAbbreviation>Curr Protoc</ISOAbbreviation></Journal><ArticleTitle>A Mouse Model of MHV-1 Virus Infection for Study of Acute and Long COVID Infection.</ArticleTitle><Pagination><StartPage>e896</StartPage><MedlinePgn>e896</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cpz1.896</ELocationID><Abstract><AbstractText>COVID-19, caused by SARS-CoV-2, has had a significant global impact. While vaccines and treatments have reduced severe cases and deaths, the long-term effects are not yet well understood. Current models used for research, such as non-human primates and transgenic mice, are expensive and require scarce Biosafety Level-3 (BSL-3) laboratories, thereby limiting their practicality. However, the mouse hepatitis virus 1 (MHV-1) mouse model offers a promising alternative. This surrogate model can be investigated in more widely available Biosafety Level-2 (BSL-2) laboratories. Furthermore, mice are affordable and easy to handle, and utilizing MHV-1 as a surrogate for SARS-CoV-2 eliminates the need for costly transgenic mice. Importantly, the MHV-1 model successfully recapitulates COVID-19-related clinical symptoms, weight loss, multiorgan pathological changes and failure in acute stages, irreversible neurological complications, and other long-term organ dysfunction post-infection, which are similar to available human data post-COVID-19. To assist researchers in establishing and using the MHV-1 mouse model, this protocol offers comprehensive guidance encompassing procedures for animal preparation, induction of viral infection, clinical observation, pathological changes, and tissue analysis for mechanistic studies, thereby yielding valuable insights into disease mechanisms and progression. By adopting the MHV-1 model and the provided protocols, researchers can effectively circumvent financial constraints and the limited availability of BSL-3 laboratories, thus facilitating a more accessible and cost-effective approach to investigating the underlying mechanisms of SARS-CoV-2 pathophysiology and exploring potential therapeutic interventions. &#xa9; 2023 Wiley Periodicals LLC. Basic Protocol: Induction of mouse hepatitis virus 1 (MHV-1) infection in A/J mice Support Protocol 1: Histological evaluation Support Protocol 2: Liver enzyme measurement Support Protocol 3: Western blot analysis of aquaporin expression Support Protocol 4: mRNA measurement Support Protocol 5: Immunohistochemistry/immunofluorescence Support Protocol 6: Tissue water measurement.</AbstractText><CopyrightInformation>&#xa9; 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Masciarella</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>University of Miami Miller School of Medicine, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gregorio</LastName><ForeName>Dibe M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>College of Arts and Sciences, University of Miami, Coral Gables, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramamoorthy</LastName><ForeName>Rajalakshmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Hussain</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayakumar</LastName><ForeName>Arumugam R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paidas</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>College of Arts and Sciences, University of Miami, Coral Gables, Florida, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R41 HD085744</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Protoc</MedlineTA><NlmUniqueID>101773894</NlmUniqueID><ISSNLinking>2691-1299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006517" MajorTopicYN="Y">Murine hepatitis virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MHV-1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mice</Keyword><Keyword MajorTopicYN="N">surrogate model</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST STATEMENT: Dr. Paidas is a Scientific Advisory Board Member of BioIncept, LLC with stock options. The other authors have no conflict of interest or competing interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37867460</ArticleId><ArticleId IdType="mid">NIHMS1930187</ArticleId><ArticleId IdType="pmc">PMC10606938</ArticleId><ArticleId IdType="doi">10.1002/cpz1.896</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caldera-Crespo LA, Paidas MJ, Roy S, Schulman CI, Kenyon NS, Daunert S, and Jayakumar AR 2021. Experimental Models of COVID-19. Front. Cell. Infect. Microbiol 11, 792584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791197</ArticleId><ArticleId IdType="pubmed">35096645</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakumar AR, Valdes V, and Norenberg MD 2011. The Na-K-Cl cotransporter in the brain edema of acute liver failure. J. Hepatol 54(2):272&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">21056502</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Shamaladevi N, Abuzamel M, Johnstone J, Gaidosh G, Rama Rao KV, and Norenberg MD 2014a. Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies. J. Neurochem 131(3):333&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4364553</ArticleId><ArticleId IdType="pubmed">25040426</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakumar AR, Valdes V, Tong XY, Shamaladevi N, Gonzalez W, and Norenberg MD 2014b. Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure. Transl. Stroke Res 5(1), 28&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4714761</ArticleId><ArticleId IdType="pubmed">24443056</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Mohamed AB, Norenberg MD, Saad A, Barry AF, Colon C, Kenyon NS, and Jayakumar AR 2021. Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19. Viruses, 13(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8473123</ArticleId><ArticleId IdType="pubmed">34578284</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Sampath N, Schindler EA, Cosio DS, Ndubizu CO, Shamaladevi N, Kwal J, Rodriguez S, Ahmad A, Kenyon NS, and Jayakumar AR 2022a. Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide. Front. Pharmacol 13, 864798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196045</ArticleId><ArticleId IdType="pubmed">35712703</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Cosio DS, Ali S, Kenyon NS, and Jayakumar AR 2022b. Long-Term Sequelae of COVID-19 in Experimental Mice. Mol. Neurobiol 59(10), 5970&#x2013;5986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9281331</ArticleId><ArticleId IdType="pubmed">35831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Rump K, and Adamzik M 2018. Function of Aquaporins in Sepsis: a Systematic Review. Cell. Biosci 8, 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807818</ArticleId><ArticleId IdType="pubmed">29449936</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuerger C, Abdulla S, and Puglisi A
2022. Mapping Biosafety Level-3 Laboratories by Publications. Center for Security and Emerging Technology. Retrieved from https://cset.georgetown.edu/publication/mapping-biosafety-level-3-laboratories-by-publications/.</Citation></Reference><Reference><Citation>Wiggli B, Imhof E, Meier CA, and Laifer G 2013. Water, Water, Everywhere. Acute Parvovirus B19 Infection. Lancet 381 (9868), 776.</Citation><ArticleIdList><ArticleId IdType="pubmed">23472922</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2020. WHO COVID-19 Dashboard. Retrieved from https://covid19.who.int/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>